Literature DB >> 29167394

Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease.

Christina D Orrú1, Jue Yuan2, Brian S Appleby2,3,4, Baiya Li2,5, Yu Li2,6, Dane Winner7, Zerui Wang2,8, Yi-An Zhan2,6, Mark Rodgers2, Jason Rarick2, Robert E Wyza9, Tripti Joshi9, Gong-Xian Wang6, Mark L Cohen2, Shulin Zhang2, Bradley R Groveman1, Robert B Petersen10, James W Ironside11, Miguel E Quiñones-Mateu2,7, Jiri G Safar2,4, Qingzhong Kong12,3,4,13, Byron Caughey14, Wen-Quan Zou12,3,4,6,8,13,15.   

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD), the most common human prion disease, is transmissible through iatrogenic routes due to abundant infectious prions [misfolded forms of the prion protein (PrPSc)] in the central nervous system (CNS). Some epidemiological studies have associated sCJD risk with non-CNS surgeries. We explored the potential prion seeding activity and infectivity of skin from sCJD patients. Autopsy or biopsy skin samples from 38 patients [21 sCJD, 2 variant CJD (vCJD), and 15 non-CJD] were analyzed by Western blotting and real-time quaking-induced conversion (RT-QuIC) for PrPSc Skin samples from two patients were further examined for prion infectivity by bioassay using two lines of humanized transgenic mice. Western blotting revealed dermal PrPSc in one of five deceased sCJD patients and one of two vCJD patients. However, the more sensitive RT-QuIC assay detected prion seeding activity in skin from all 23 CJD decedents but not in skin from any non-CJD control individuals (with other neurological conditions or other diseases) during blinded testing. Although sCJD patient skin contained ~103- to 105-fold lower prion seeding activity than did sCJD patient brain tissue, all 12 mice from two transgenic mouse lines inoculated with sCJD skin homogenates from two sCJD patients succumbed to prion disease within 564 days after inoculation. Our study demonstrates that the skin of sCJD patients contains both prion seeding activity and infectivity, which raises concerns about the potential for iatrogenic sCJD transmission via skin.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29167394      PMCID: PMC5744860          DOI: 10.1126/scitranslmed.aam7785

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  38 in total

1.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

Review 2.  Molecular biology and pathology of prion strains in sporadic human prion diseases.

Authors:  Pierluigi Gambetti; Ignazio Cali; Silvio Notari; Qingzhong Kong; Wen-Quan Zou; Witold K Surewicz
Journal:  Acta Neuropathol       Date:  2010-11-07       Impact factor: 17.088

3.  Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains.

Authors:  Jue Yuan; Xiangzhu Xiao; John McGeehan; Zhiqian Dong; Ignazio Cali; Hisashi Fujioka; Qingzhong Kong; Geoff Kneale; Pierluigi Gambetti; Wen-Quan Zou
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

4.  Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice.

Authors:  D M Taylor; I McConnell; H Fraser
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

5.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

6.  Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.

Authors:  Mark W Head; Tristan J R Bunn; Matthew T Bishop; Victoria McLoughlin; Suzanne Lowrie; Clive S McKimmie; Michelle C Williams; Linda McCardle; Jan MacKenzie; Richard Knight; Robert G Will; James W Ironside
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

7.  Towards an age-dependent transmission model of acquired and sporadic Creutzfeldt-Jakob disease.

Authors:  Jesús de Pedro-Cuesta; Ignacio Mahillo-Fernandez; Miguel Calero; Alberto Rábano; Mabel Cruz; Åke Siden; Pablo Martínez-Martín; Henning Laursen; María Ruiz-Tovar; Kåre Mølbak
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

8.  Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Authors:  Richard M Gibson; Ashley M Meyer; Dane Winner; John Archer; Felix Feyertag; Ezequiel Ruiz-Mateos; Manuel Leal; David L Robertson; Christine L Schmotzer; Miguel E Quiñones-Mateu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

9.  Bovine spongiform encephalopathy infectivity in greater kudu (Tragelaphus strepsiceros).

Authors:  Andrew A Cunningham; James K Kirkwood; Michael Dawson; Yvonne I Spencer; Robert B Green; Gerald A H Wells
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

10.  Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008.

Authors:  Tsuyoshi Hamaguchi; Moeko Noguchi-Shinohara; Ichiro Nozaki; Yosikazu Nakamura; Takeshi Sato; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Masahito Yamada
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more
  51 in total

1.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

Review 2.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

3.  Prion disease: Skin is a source of infectious prions in sCJD.

Authors:  Shimona Starling
Journal:  Nat Rev Neurol       Date:  2017-12-08       Impact factor: 42.937

4.  Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.

Authors:  Michael A Metrick; Natalia do Carmo Ferreira; Eri Saijo; Andrew G Hughson; Allison Kraus; Christina Orrú; Michael W Miller; Gianluigi Zanusso; Bernardino Ghetti; Michele Vendruscolo; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

5.  Breakthroughs in antemortem diagnosis of neurodegenerative diseases.

Authors:  Glenn C Telling
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-30       Impact factor: 11.205

6.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

7.  Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Geidy E Serrano; Vellareddy Anantharam; Arthi Kanthasamy; Charles H Adler; Thomas G Beach; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 10.338

Review 8.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.

Authors:  Peter Hermann; Brian Appleby; Jean-Philippe Brandel; Byron Caughey; Steven Collins; Michael D Geschwind; Alison Green; Stephane Haïk; Gabor G Kovacs; Anna Ladogana; Franc Llorens; Simon Mead; Noriyuki Nishida; Suvankar Pal; Piero Parchi; Maurizio Pocchiari; Katsuya Satoh; Gianluigi Zanusso; Inga Zerr
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

9.  Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC.

Authors:  Jung-Youn Han; Chaewon Shin; Young Pyo Choi
Journal:  Viruses       Date:  2021-04-26       Impact factor: 5.048

Review 10.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.